Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg

Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Foodamp;Drug Administration (U.S. FDA) for its Lacosamide Tablets1 U

Related Keywords

Mumbai ,Maharashtra ,India ,Robert Crockart ,States Glenmark ,United States Fooddrug Administration ,Ucb Inc ,Glenmark Pharmaceuticals Inc ,Company Rankings ,Glenmark Pharmaceuticals Ltd ,National Sales Perspectives ,United States ,Lacosamide Tablets ,Chief Commercial Officer ,Vimpat Tablets ,Generics Bulletin ,Dow Jones Sustainability Index ,Corporate Sustainability ,Stock Market News ,Approved ,Sales ,Company ,World ,Company Has ,Enerics And ,Approval ,January ,Lobally ,